You are here

Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: A phase III, randomized, multicentre, lot-to-lot consistency study.

Pubmed ID: 
26232542
Year: 
2015
Month: 
SEP
Volume: 
33
Issue: 
39
Citation: 
Perrett KP, McVernon J, Richmond PC, Marshall H, Nissen M, August A, Percell S, Toneatto D, Nolan T. Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: A phase III, randomized, multicentre, lot-to-lot consistency study. VACCINE 33 (39) : 5217 - 24(2015) PubMed (Grant IDs: 1016272)